SCHEMBL7456245

SCHEMBL7456245

CCCc1c(CO[Si](C)(C)C(C)(C)C)ccc2[nH]c(CCl)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7455589 0.89 — —
SCHEMBL7450159 0.73 KDM4E (0.34) —
SCHEMBL28193856 0.73 HTT (0.36) —
SCHEMBL7444504 0.72 GRIN2B (0.37) —
SCHEMBL28193295 0.70 CCNB2 (0.33) —
SCHEMBL28193851 0.69 HTT (0.34) —
SCHEMBL28193908 0.68 HTT (0.40) —
SCHEMBL28193478 0.67 CCNB2 (0.36) —
SCHEMBL7464101 0.67 MPO (0.32) —
SCHEMBL7022293 0.67 CHEK1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165557-A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORPORATION (US) 2002-01-02 — — EP disclosed
WO-2000059905-A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORPORATION (US) 2000-10-12 — — WO disclosed
Send feedback